BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · IEX Real-Time Price · USD
143.93
-0.96 (-0.66%)
Jul 2, 2024, 4:00 PM EDT - Market closed

BeiGene Revenue

BeiGene had revenue of $2.76B in the twelve months ending March 31, 2024, with 77.42% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $751.65M with 67.85% year-over-year growth. In the year 2023, BeiGene had annual revenue of $2.46B with 73.65% growth.

Revenue (ttm)
$2.76B
Revenue Growth
+77.42%
P/S Ratio
5.73
Revenue / Employee
$260,625
Employees
10,600
Market Cap
15.83B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.46B1.04B73.65%
Dec 31, 20221.42B239.64M20.37%
Dec 31, 20211.18B867.41M280.83%
Dec 31, 2020308.87M-119.34M-27.87%
Dec 31, 2019428.21M229.99M116.03%
Dec 31, 2018198.22M-40.17M-16.85%
Dec 31, 2017238.39M237.32M22,179.16%
Dec 31, 20161.07M-7.75M-87.86%
Dec 31, 20158.82M-4.22M-32.37%
Dec 31, 201413.04M1.89M16.93%
Dec 31, 201311.15M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molina Healthcare 35.85B
Baxter International 14.89B
Quest Diagnostics 9.29B
Illumina 4.49B
Waters 2.91B
Genmab 2.57B
United Therapeutics 2.50B
BioMarin Pharmaceutical 2.47B
Revenue Rankings